Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset alzheimer’s disease

Dementia and Geriatric Cognitive Disorders

Volumn 8, Issue 6, 1997, Pages 337-342

  Licastro, Federico ^a   Sirri, Valentina ^a   Trerè, Davide ^a   Davis, Lisabeth Jane ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alzheimer s disease; Monomers; Polymers; Serum 1 antichymotrypsin

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; INTERLEUKIN 6; MONOMER; POLYCLONAL ANTIBODY; SERINE PROTEINASE INHIBITOR;

AFFINITY CHROMATOGRAPHY; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; MULTIINFARCT DEMENTIA; ONSET AGE; OPTICAL DENSITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL;

EID: 0030667195     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106652     Document Type: Article

References (41)

1. Glcnner GG: Current knowledge of amyloid deposit as applied to senile plaques and congo-philic angiopathy, Aging 1978;7:493-501.
2. Miyakawa T, Shimoji A, Kuramoto R, Higuchi Y: The relationship between senile plaques and cerebral blood vessels in Alzheimer’s disease and senile dementia, Virchows Arch 1982:40: 121-129.
3. Wisniewski HM, Narang HK, Terry RD: Neurofibrillary tangles of paired helical filaments, J Neurol Sci 1976;27:173-181.
4. Kang J, Lemaire HG, Untcrbeck A, Salbaum JM, Masters CL, Grzcschik KH, Mullhaup G, Bcyrcuthcr K, Muller HB: The precursor of Alzheimer's disease A4 protein resembles a cell-surfacc receptor, Nature 1987:325:733-736.
5. Joachim CL, Morris J, Selkoe DJ: Clinically diagnosed Alzheimer’s disease: Autopsy results in 150 cases, Ann Neurol 1988;24:50-56.
6. Masters CL, Simms G, Wcinmann NA, Mult-haup G, McDonald BL, Beyicuther K: Amyloid plaque core protein in Alzheimer's disease and Down’s syndrome, Proc Natl Acad Sci USA 1985:82:4245-4249.
7. Abraham CR, Selkoe DJ, Potter H: Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer’s disease, Cell 1988:52:487-501.
8. Abraham CR: The role of acute-phase protein apantichymotrypsin in brain dysfunction and injury', Res Immunol 1992;143:631-636.
9. Matsubara E, Hirai S, Amari M, Shoji M, Yamaguchi H, Okamoto K, Ishiguro K, Hari-gaya Y, Wakabayashi K: al-Antichymotrypsin as a possible biochemical marker for Alzheim-cr-typc dementia, Ann Neurol 1990;28:561-567.
10. Licastro F, Davis LJ, Morini MC, Cucinotta D, Savorani G: Cerebrospinal fluid of patients with senile dementia of Alzheimer’s type shows an increased inhibition of a-chymotrypsin, Alzheimer Dis Assoc Disord 1994;8:241-249.
11. Nakamura T, Shoji M, Harigava Y, Watanabe M, Hosoda K, Cheung TT, ShalTcr LM, Goldc TE, Younkin LH, Younkin SG, Hirai S: Amyloid P protein levels in cerebrospinal fluid are e'evatcd in early-onsel Alzheimer's disease, Ann Neurol 1994;36:903-911.
12. Licastro F, Pametti L, Morini MC, Davis LJ, Cucinotta D, Gaiti A, Scnin U: Acute phase reactant apantichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer’s disease, Alzheimer Dis Assoc Disord 1995:9:112-118.
13. Brugge K, Katzman R, Hill LR, Hansen LA, Saitoh T: Serological apantichymotrypsin in Down’s syndrome and Alzheimer’s disease, Ann Neurol 1992;32:193-207.
14. Hinds TR, Kukull WA, Van Belle G, Schellen-berg GD, Villacrcss ER, Larson EB: Relationship between scrum ai-antichymotrypsin and Alzheimer's disease, Ncurobiol Aging 1994; 15: 21-27.
15. Lieberman J, Schlcissncr L, Tachiki KH, Kling AS: Scrum ai-antichymotrypsin level as a marker for Alzheimer type dementia, Neurobio! Aging 1995;16:747-753.
16. Licastro F, Morini MC, Polazzi E, Davis LJ: Increased scrum ai-antichymotrypsin in patients with probable Alzheimer’s disease, An acute phase reactant without the peripheral acute phase response, J Ncuroimmunol 1995; 57:71-75.
17. Furby A, Leys D, Dclacourte A, Buee L, Soe-taen G, Petit H: Arc alpha-I-anlichymotrypsin and inter-alpha-lrypsin inibitor peripheral markers of Alzheimer's disease? J Neurol Ncu-rosurg Psychiatry 1991:54:469.
18. Kuiper MA, van-Kamp GJ, Bergmans PL, Scheltens P, Wolters EC: Serum alpha 1-anti-chymotrypsin is not a useful marker for Alzheimer’s disease or dementia in Parkinson's discac, J Neural Transm Park Dis Dement Sect 1993;6:145-149.
19. Pirtilla T, Mehta PD, Frey H, Wisniewski HM: ai-antichymotrypsin and IL-1P are not increased in CSF or serum in Alzheimer's disease, Neurobiol Aging 1994; 15:313-317.
20. Licastro F, Davis LJ, Polazzi E, Rossi S, Cucinotta D: Serological ai-antichymotrypsin in patients with probable senile dementia of Alzheimer’s type: A short term longitudinal study, Alzheimer Dis Assoc Disord 1996; 10:192-196.
21. McKahnn G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of NINCDS-ADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheimer's disease, Neurology 1984;34:939-944.
22. Folstein MF, Folstein SE, McHugh PR: ‘Mini mental state’: A practical method for grading the cognitive stale of patients lor the clinician, J Psychiatr Res 1975;12:189-198.
23. Rcisbcrg B, Ferris SH, dc Leon MJ, Crook T: The Global Deterioration Scale for assessment of primary degenerative dementia, Am J Psychiatry 1982;139:1136-1139.
24. Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4, Nature 1970:227:680-685.
25. Lainc A, Hayern A: Purification and characterization of ai-antichymotrypsin from human pleural fluid and human serum, Biochim Bio-physActa 1981;668:429-438.
26. Travis J, Salvesen GS: Human plasma proteinase inhibitors, Annu Rev Biochcm 1983;52: 655-709.
27. Kamboh MI, Sanghera DK, Ferrell RE, De-Kosky ST: APOE4-associatcd Alzheimer’s disease risk is modified by ai-antichymotrypsin polymorphism, Nat Genetics 1995; 10.486-488.
28. Talbot C, Houlden H, Craddock N, Crook R, Hutton M, Lendon C, Prihar G, Morris JC, Hardy J, Goatc A: Polymorphism in ACT gene may lower age onset of Alzheimer’s disease, Neuroreport 1996;7:534-536.
29. Ma J, Yee A, Brewer HB, Das S, Potter H: Amyloid-associated proteins apantichymo-trypsin and apolipoprotcin E promote assembly of Alzheimer ß-protein into filaments, Nature 1994;372:92-94.
30. Fraser PE, Nguyen JT, McLachlan DR, Abraham CR, Kirschncr DA: ai-Antichymotrypsin binding to Alzheimer Aß peptides is sequence specific and induces fibril disaggregation in vitro, J Ncurochcm 1993;61:298-305.
31. Eriksson S, Janciauskicne S, Lannfelt L: ap Antichymotrypsin regulates Alzheimer ß-amy-loid peptide fibril formation, Proc Natl Acad Sci USA 1995;92:2313-2317.
32. Cox DW, Billingsley GD, Callahan JW: Aggregation of plasma Z type upantitrypsin suggests basic defect for the deficiency, FEBS Lett 1986; 205:255-260.
33. Elliott PR, Lomas DA, Carrcll RW, Abrahams JP: Inhibitory conformation of the reactive loop of apantitrypsin, Nat Struct Biol 1996:3: 676-681.
34. Stein PE, Carrcll RW: What do disfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 1995;2:96-113.
35. Lomas DA, Evans DL, Slone SR, Chang WSM, Carrel RW: Effect of the Z mutation on the physical and inhibitory properties of apanti-trypsin, Biochemistry 1993;32:500-508.
36. Patston PA, Haucrt J, Michaud M, Shapira M: Formation and propertiesofCl-inhibitor polymers, FEBS Lett 1995;368:401-404.
37. Zhang H, Stemberger NH, Rubistein LJ, Herman MIL, Binder LI, Stemberger LA: Abnormal processing of multiple proteins in Alzheimer disease, Proc Natl Acad Sci USA 1989; 86:8045-8049.
38. Janciauskicne S, Eriksson S, Wright HT: A specific structural interaction of Alzheimer’s peptide Aßl-42 with apantichymotrypsin, Nat Struct Biol 1996;3:668-671.
39. Lukas CM, Christanson DA: Is the binding of ß-amyloid protein to antichymotrypsin in Alzheimer plaques mediated by a ß-strand insertion? Proteins Struct Funcl Genet 1996:25: 420-424.
40. Joachim CL, Mori H, Selkoe DJ: Amyloid ß-protcin deposition in tissue other than brain of Alzheimer's disease, Nature 1989:341:226-230.
41. Roses AD: On the metabolism of apolipoprotcin E and Alzheimer disease, Exp Neurol 1995;132:149-156.